ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,043.58
0.50%
US Tech 100
16,950.00
0.53%
다우존스 지수
38,119.72
0.57%
Bitcoin
59,170.02
1.61%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Oramed Pharmaceuticals Inc (ORMP)

  7. Oramed Pharmaceuticals Inc (ORMP) 뉴스

ORMP Oramed Pharmaceuticals Inc

2.28
-0.06 (-2.56%)
최종 업데이트: 23:48:18
15분 지연
기업명 주식 심볼 시장 주식 타입
Oramed Pharmaceuticals Inc ORMP 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.06 -2.56% 2.28 23:48:18
개장가 저가 고가 종가 전일 종가
2.31 2.24 2.34 2.34
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
19/03/202422:00GLOBEScilex Holding Company Announces Repayment in Full of the..
07/03/202407:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/02/202422:42EDGAR2Form 8-K - Current report
20/02/202422:30PRNUSOramed Letter to Shareholders
31/01/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202406:45EDGAR2Form 8-K - Current report
20/01/202406:45EDGAR2Form 8-K - Current report
09/01/202406:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202403:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/12/202323:26EDGAR2Form 8-K - Current report
19/12/202306:45EDGAR2Form 8-K - Current report
10/11/202307:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/09/202305:34EDGAR2Form 8-K - Current report
23/09/202300:38PRNUSSorrento Therapeutics, Inc. Announces the Consummation of..
22/09/202307:11PRNUSOramed Announces $101,875,000 Short-Term Senior Secured Note..
22/09/202305:05GLOBEScilex Holding Company Announces the Consummation of the..
13/09/202322:00GLOBEScilex Holding Company Enters into Non-Binding Term Sheets..
13/09/202321:47EDGAR2Form 8-K - Current report
11/08/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202321:30EDGAR2Form 8-K - Current report
07/08/202322:20EDGAR2Form 8-K - Current report
02/08/202320:45PRNUSOramed Signs Term Sheet with HTIT to Create a Joint Venture..
14/07/202306:00EDGAR2Form 8-K - Current report
20/06/202320:55PRNUSOramed to Present at the 83rd American Diabetes Association..
18/05/202320:55PRNUSOramed to Present at Novel Therapies for Type 2 Diabetes &..
15/05/202322:05PRNUSOramed Announces that its Chinese Partner, HTIT, has..

최근 히스토리

NASDAQ
ORMP
Oramed Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유